Universal Ibogaine Statistics
Total Valuation
IBOGF has a market cap or net worth of 5.65 million. The enterprise value is 7.44 million.
| Market Cap | 5.65M |
| Enterprise Value | 7.44M |
Important Dates
The last earnings date was Friday, June 27, 2025.
| Earnings Date | Jun 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 308.61M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +38.51% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 280.11M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.79 |
| PB Ratio | 28.68 |
| P/TBV Ratio | 28.68 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -6.96 |
| EV / Sales | 4.93 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -15.49 |
Financial Position
The company has a current ratio of 0.39, with a Debt / Equity ratio of 9.45.
| Current Ratio | 0.39 |
| Quick Ratio | 0.37 |
| Debt / Equity | 9.45 |
| Debt / EBITDA | n/a |
| Debt / FCF | -3.88 |
| Interest Coverage | -4.50 |
Financial Efficiency
Return on equity (ROE) is -161.37% and return on invested capital (ROIC) is -12.30%.
| Return on Equity (ROE) | -161.37% |
| Return on Assets (ROA) | -9.46% |
| Return on Invested Capital (ROIC) | -12.30% |
| Return on Capital Employed (ROCE) | -35.38% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.44 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +157.87% in the last 52 weeks. The beta is 6.50, so IBOGF's price volatility has been higher than the market average.
| Beta (5Y) | 6.50 |
| 52-Week Price Change | +157.87% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 50.74 |
| Average Volume (20 Days) | 127,936 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IBOGF had revenue of 1.49 million and -1.07 million in losses. Loss per share was -0.00.
| Revenue | 1.49M |
| Gross Profit | 258,101 |
| Operating Income | -510,726 |
| Pretax Income | -1.07M |
| Net Income | -1.07M |
| EBITDA | -259,282 |
| EBIT | -510,726 |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 92,448 in cash and 1.86 million in debt, giving a net cash position of -1.77 million.
| Cash & Cash Equivalents | 92,448 |
| Total Debt | 1.86M |
| Net Cash | -1.77M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 196,968 |
| Book Value Per Share | 0.00 |
| Working Capital | -888,816 |
Cash Flow
In the last 12 months, operating cash flow was -465,185 and capital expenditures -14,977, giving a free cash flow of -480,162.
| Operating Cash Flow | -465,185 |
| Capital Expenditures | -14,977 |
| Free Cash Flow | -480,162 |
| FCF Per Share | n/a |
Margins
Gross margin is 17.31%, with operating and profit margins of -34.25% and -71.66%.
| Gross Margin | 17.31% |
| Operating Margin | -34.25% |
| Pretax Margin | -71.66% |
| Profit Margin | -71.66% |
| EBITDA Margin | -17.39% |
| EBIT Margin | -34.25% |
| FCF Margin | n/a |
Dividends & Yields
IBOGF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -38.51% |
| Shareholder Yield | n/a |
| Earnings Yield | -18.91% |
| FCF Yield | -8.50% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |